Advanced Cancer Therapeutics Overview
- Year Founded
-
2007

- Status
-
Out of Business
- Latest Deal Type
-
Out of Business
Advanced Cancer Therapeutics General Information
Description
Developer of oncology therapeutics designed to prevent and treat cancer. The company develops and manufactures anti-cancer products from the preclinical stage of development through the completion of phase one clinical trials, enabling doctors to begin treatment as early as possible, resulting in a successful treatment.
Contact Information
Corporate Office
- 300 East Market Street
- Suite 280
- Louisville, KY 40202
- United States
Corporate Office
- 300 East Market Street
- Suite 280
- Louisville, KY 40202
- United States
Advanced Cancer Therapeutics Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
8. Out of Business | Completed | Out of Business | ||||
7. Later Stage VC | 07-Jul-2017 | Completed | Generating Revenue | |||
6. Grant | 11-Jan-2017 | Completed | Generating Revenue | |||
5. Early Stage VC | 01-Jul-2010 | Completed | Pre-Clinical Trials | |||
4. Early Stage VC | Completed | Pre-Clinical Trials | ||||
3. Grant | 23-Feb-2010 | Completed | Pre-Clinical Trials | |||
2. Seed Round | 23-Feb-2010 | $250K | $250K | Completed | Pre-Clinical Trials | |
1. University Spin-Out | 01-Jan-2007 | Completed | Startup |
Advanced Cancer Therapeutics Comparisons
Industry
Financing
Details
Advanced Cancer Therapeutics Competitors (25)
One of Advanced Cancer Therapeutics’s 25 competitors is Centrose, a Venture Capital-Backed company based in Middleton, WI.
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Centrose | Venture Capital-Backed | Middleton, WI | ||||
Iovance Biotherapeutics | Corporation | San Carlos, CA | ||||
NexImmune | Formerly VC-backed | Gaithersburg, MD | ||||
TScan Therapeutics | Formerly VC-backed | Waltham, MA | ||||
Aura Biosciences | Formerly VC-backed | Cambridge, MA |
Advanced Cancer Therapeutics Patents
Advanced Cancer Therapeutics Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
CA-2929818-A1 | Modified dna quadruplex-forming oligonucleotides and methods of use | Inactive | 06-Nov-2013 | ||
US-20160281090-A1 | Modified dna quadruplex-forming oligonucleotides and methods of use | Inactive | 06-Nov-2013 | ||
ES-2629932-T3 | Pfkfb3 inhibitor and methods of use as a cancer therapeutic | Active | 29-Mar-2012 | ||
AU-2013240340-B2 | Pfkfb3 inhibitor and methods of use as an anti-cancer therapeutic | Inactive | 29-Mar-2012 | ||
US-9649305-B2 | Pfkfb3 inhibitor and methods of use as an anti-cancer therapeutic | Inactive | 29-Mar-2012 | A61K31/4709 |
Advanced Cancer Therapeutics FAQs
-
When was Advanced Cancer Therapeutics founded?
Advanced Cancer Therapeutics was founded in 2007.
-
Where is Advanced Cancer Therapeutics headquartered?
Advanced Cancer Therapeutics is headquartered in Louisville, KY.
-
What industry is Advanced Cancer Therapeutics in?
Advanced Cancer Therapeutics’s primary industry is Drug Discovery.
-
Is Advanced Cancer Therapeutics a private or public company?
Advanced Cancer Therapeutics is a Private company.
-
What is Advanced Cancer Therapeutics’s current revenue?
The current revenue for Advanced Cancer Therapeutics is
. -
How much funding has Advanced Cancer Therapeutics raised over time?
Advanced Cancer Therapeutics has raised $10.4M.
-
Who are Advanced Cancer Therapeutics’s competitors?
Centrose, Iovance Biotherapeutics, NexImmune, TScan Therapeutics, and Aura Biosciences are some of the 25 competitors of Advanced Cancer Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »